A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
Phase of Trial: Phase II
Latest Information Update: 15 May 2016
At a glance
- Drugs KD 026 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Kadmon Corporation
- 10 Jun 2017 Biomarkers information updated
- 15 Apr 2016 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 26 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.